This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Ryan Gilbreth: Innovator in Cancer Treatment
Introduction
Ryan Gilbreth is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of advanced therapeutic methods.
Latest Patents
Ryan holds 1 patent for his work titled "Compositions and methods of treating cancer with chimeric antigen receptors." This patent focuses on the use of armored chimeric antigen receptor cells to treat cancer, showcasing his commitment to improving patient outcomes through innovative medical solutions.
Career Highlights
Throughout his career, Ryan has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and MedImmune Limited. His experience in these organizations has allowed him to develop and refine his expertise in cancer therapies.
Collaborations
Ryan has collaborated with several professionals in his field, including Michael Glen Overstreet and Gordon Moody. These partnerships have contributed to his success and the advancement of his research.
Conclusion
Ryan Gilbreth's work in cancer treatment exemplifies the impact of innovation in medicine. His dedication to developing effective therapies continues to inspire advancements in the fight against cancer.